Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Up – What’s Next?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $6.58, but opened at $6.79. Coloplast A/S shares last traded at $6.8140, with a volume of 15,818 shares traded.

Analyst Upgrades and Downgrades

Separately, Kepler Capital Markets upgraded shares of Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Coloplast A/S has an average rating of “Hold”.

Coloplast A/S Stock Up 2.4%

The company has a current ratio of 1.75, a quick ratio of 1.09 and a debt-to-equity ratio of 1.66. The firm’s fifty day moving average price is $6.26 and its 200-day moving average price is $6.65. The company has a market cap of $15.66 billion, a price-to-earnings ratio of 36.58, a price-to-earnings-growth ratio of 2.15 and a beta of 0.13.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings data on Tuesday, August 18th. The company reported $0.10 EPS for the quarter, hitting the consensus estimate of $0.10. The business had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.12 billion. Coloplast A/S had a return on equity of 38.81% and a net margin of 9.68%. Sell-side analysts predict that Coloplast A/S Sponsored ADR will post 0.38 earnings per share for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.